Related Experiment Videos
Oxidation of methamphetamine and methylenedioxymethamphetamine by CYP2D6
L Y Lin1, E W Di Stefano, D A Schmitz
1Department of Molecular and Medical Pharmacology, University of California, Los Angeles, 90095-1735, USA.
Summary
Cytochrome P450 2D6 (CYP2D6) is crucial for methamphetamine (MeAmp) metabolism, including 4-hydroxylation and N-demethylation. This enzyme
Area of Science:
- Pharmacology and Toxicology
- Drug Metabolism
- Enzymology
Background:
- Methamphetamine (MeAmp) abuse is rising, necessitating effective addiction treatments.
- Treatment strategies may involve drugs metabolized by similar pathways as MeAmp.
- Understanding MeAmp metabolism is vital for predicting drug interactions and treatment responses.
Purpose of the Study:
- To investigate the role of Cytochrome P450 2D6 (CYP2D6) in methamphetamine metabolism.
- To determine if CYP2D6 catalyzes the 4-hydroxylation and N-demethylation of MeAmp.
- To assess potential pharmacokinetic interactions and genetic influences on MeAmp metabolism.
Main Methods:
- Studies using human liver microsomes, including those from CYP2D6 poor metabolizers.
- Correlation analysis between MeAmp metabolism and known CYP2D6 substrates (metoprolol, MDMA).
- Experiments with recombinant CYP2D6 expressed in yeast.
Main Results:
- CYP2D6 significantly contributes to the 4-hydroxylation of MeAmp.
- CYP2D6 also catalyzes the N-demethylation of MeAmp.
- The rate of MeAmp 4-hydroxylation by CYP2D6 is slower than MDMA demethylenation; MDMA is not N-demethylated by CYP2D6.
Conclusions:
- CYP2D6 plays a major role in methamphetamine metabolism.
- Pharmacokinetic interactions are likely with drugs sharing CYP2D6 metabolic pathways.
- Genetic variations in CYP2D6 could lead to altered responses to MeAmp.